HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Vantyghem, M.-C. Articles by Wemeau, J.-L. Search for Related Content PubMed PubMed Citation Articles by Vantyghem, M.-C. Articles by Wemeau, J.-L.

Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department

¹ Endocrinology and Metabolism Department, ² Biochemistry Department and ³ Nuclear Medicine Laboratory, Lille University Hospital, 6, Rue du Pr Laguesse, 59037 Lille cedex, France

(Correspondence should be addressed to M-C Vantyghem; Email: mc-vantyghem{at}chru-lille.fr)

Objective: The aim of this study was to describe HFE genotype in a population of patients with altered iron markers recruited in an Endocrinology Department and to define the possible phenotype–genotype relationships.

Methods: A total of 156 patients with high serum ferritin concentrations (>300 ng/ml) or transferrin saturation (>45%) (I group), and a control group of 106 healthy subjects (C group) underwent HFE genotyping (classical C282Y and H63D mutations). We also examined the main genetic features of subgroups in I according to the presence (D) or the absence (ND) of diabetes.

Results: (1) The genotypes were significantly different in the I and C groups (P<0.001), with an increased frequency of major 282Y allele in the I group (35% vs 7.5%), but not of minor 63D allele (17 vs 18.5%). (2) The genotype of D and ND groups also differed (P<0.0001), with a lower frequency of C282 heterozygosity (P<0.0001) in the D group, and a higher prevalence of H63D heterozygosity in the D vs ND groups (P<0.01). (3) The phenotypic comparison of D and ND groups also showed a higher mean body mass index, age, and serum ferritin concentration, as well as an increased proportion of males with increased liver enzymes in the D group.

Conclusion: This population harboring abnormal iron markers had a different HFE genotype and a higher 282Y allele frequency than the control population. This suggests that blood iron markers could be checked in etiological investigations of metabolic disturbances to identify patients who should undergo genotyping, since approximately 20% were diagnosed with C282Y homozygosity.

This article has been cited by other articles:

				K. Cooper, J. Bryant, J. Picot, A. Clegg, P.R. Roderick, W.M. Rosenberg, and C. Patch A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations QJM, August 1, 2008; 101(8): 631 - 641. [Abstract] [Full Text] [PDF]

				J Bryant, K Cooper, J Picot, A Clegg, P Roderick, W Rosenberg, and C Patch A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations J. Med. Genet., August 1, 2008; 45(8): 513 - 518. [Abstract] [Full Text] [PDF]

				S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah The Role of Iron in Diabetes and Its Complications Diabetes Care, July 1, 2007; 30(7): 1926 - 1933. [Full Text] [PDF]